At STADA Pymepharco, transparency and compliance in sustainability are essential drivers of our collective success. As a sole wholly member in Vietnam of STADA Group (Germany), ranked among the top 4% of the most sustainable pharmaceutical companies globally (Sustainalytics), our approach to Environmental, Social, and Governance (ESG) goes beyond mere compliance – it’s key to our growth, opening pathways for financing and facilitating exports European countries.

This October, we were proud to participate in the Green Economy Forum & Exhibition (GEFE) 2024, hosted by EuroCham Vietnam. At the forum, Head of Public Affairs & Communication, Bui Hong Minh, shared our journey toward ESG excellence. From implementing the Corporate Sustainability Reporting Directive (CSRD) by 2025 to enhance transparency – building on years of following the Global Reporting Initiative (GRI) standards, we are establishing comprehensive reporting processes covering crucial aspects like energy consumption, carbon emissions, and labor practices.

Key highlights: 
  • EU Green Deal Compliance 🌱: Adapting to CSRD and the EU Taxonomy, we focus on sustainable reporting and practices.
  • ESG Commitment: With long-standing foundation in GRI, we are well-prepared to meet new directives, supporting responsible operations and resilient practices.
  • Impact for Vietnam: Through embedding ESG across our business, STADA Pymepharco empowers Vietnamese companies to prepare for future EU requirements, encouraging sustainable and export-friendly practices.

🌍 With insights gained at GEFE2024, STADA Pymepharco is excited to continue advancing sustainable practices for a greener, healthier future in Vietnam and beyond🌱

Read more about STADA Pymepharco:

 

 

 

 

 

A white globe in a pink circle AI-generated content may be incorrect.

LinkedIn icon

Facebook icon

A logo of a camera AI-generated content may be incorrect.